LTUS — Lotus Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Lotus Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2006 December 31st	2007 December 31st	C2008 December 31st	2009 December 31st	2010 December 31st
Period Length:	—	—	—	—	—
Source:	10KSB/A	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	2.09	4.56	1.28	3.95	1.34
Net Total Accounts Receivable
Net Total Receivables	7.28	20.4	8.16	1.78	1.97
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	12.8	29.4	13.8	7.69	4.54
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.81	6.17	6.9	16.2	39.3
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	21.7	36.9	63.7	84.4	103
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.33	4.79	8.98	12.6	8.05
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9.93	10.3	18.6	18.6	14.2
Non Redeemable Preferred Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	11.8	26.6	45.1	65.8	89
Total Liabilities & Shareholders' Equity	21.7	36.9	63.7	84.4	103
Total Common Shares Outstanding
Total Preferred Shares Outstanding